Testing effectiveness (Phase 2)Study completedNCT02939326
What this trial is testing
Evaluate Safety and Efficacy of a Single Treatment Cycle of EB-001 in Subjects With Glabellar Frown Lines
Who this might be right for
Glabellar Frown Lines (GL)
Bonti, Inc. 42